Day: May 6, 2020

MONTREAL, May 06, 2020 (GLOBE NEWSWIRE) — JJ Ruest, President and Chief Executive Officer of CN (TSX: CNR) (NYSE: CNI), will participate in two virtual investor conferences in May:BofA Securities 2020 Transportation and Industrials Conference on May 12 starting at 10:00 a.m. Eastern Daylight Time (EDT); RBC Capital Markets Canadian Automotive, Industrials and Transportation Conference on May 13 starting at 9:00 a.m. Eastern Daylight Time (EDT)CN will provide a live audio webcast of all remarks via the Investors’ section of the Company’s website, www.cn.ca/en/investors.CN is a true backbone of the economy, transporting more than C$250 billion worth of goods annually for a wide range of business sectors, ranging from resource products to manufactured products to consumer goods, across a rail network of approximately 20,000 route-miles...

MONTRÉAL, 06 mai 2020 (GLOBE NEWSWIRE) — Jean-Jacques Ruest, président-directeur général du CN (TSX : CNR) (NYSE : CNI), participera à deux conférences virtuelles à l’intention des investisseurs en mai :la conférence 2020 de la BofA Securities, portant sur le transport et l’industrie, qui aura lieu le 12 mai à compter de 10 h (heure avancée de l’Est); la conférence de la RBC – Marchés des capitaux, portant sur l’industrie automobile, l’industrie et les transports au Canada, qui aura lieu le 13 mai à compter de 9 h (heure avancée de l’Est).On pourra suivre la diffusion audio en direct des allocutions dans la section « Investisseurs » du site Web du CN à l’adresse www.cn.ca/fr/investisseurs.Véritable pilier de l’économie, le CN transporte annuellement des marchandises d’une valeur de plus de 250 G$ CA pour un large éventail de secteurs,...

New Drug Application (NDA) submission for trilaciclib in small cell lung cancer on track for 2Q20Rintodestrant combination trial with palbociclib expected to initiate in 2Q20Management to host webcast and conference call today at 4:30 p.m. ETRESEARCH TRIANGLE PARK, N.C., May 06, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a corporate and financial update for the first quarter ended March 31, 2020.“We have activated business continuity plans in response to the COVID-19 pandemic to ensure we can advance therapies that patients with cancer, their families, and healthcare providers are counting on to improve outcomes, and also taken actions to safeguard the well-being of our employees,” said Mark Velleca, M.D., Ph.D., Chief Executive Officer. “We are on track to complete...

First quarter total revenue of $68.8 million, up 115% year-over-yearOver 328,000 enrolled Livongo for Diabetes Members, up 100% year-over-yearIntroduces second quarter 2020 revenue guidance of $73 million to $75 million and raises 2020 full-year revenue guidance to a range of $290 million to $303 millionMOUNTAIN VIEW, Calif., May 06, 2020 (GLOBE NEWSWIRE) — Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its first quarter ended March 31, 2020.“Livongo is well positioned to provide assistance to some of the most vulnerable populations during the COVID-19 pandemic – people with chronic conditions – and our remote monitoring, digitally powered and real-time personal coaching...

ROCK HILL, S.C., May 06, 2020 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2020.For the first quarter of 2020, the company reported GAAP revenue of $134.7 million, compared to $152.0 million in the same period last year. The COVID-19 pandemic had a negative impact on these results. Printer revenue decreased by 35.5 percent. Materials revenue decreased 0.1 percent, healthcare solutions revenue decreased 7.3 percent, on demand services revenue decreased 12.8 percent and software revenue decreased 7.7 percent. The company reported first quarter 2020 GAAP loss of $0.17 per share compared to a GAAP loss of $0.22 per share in the same period last year, and non-GAAP loss of $0.04 per share compared to non-GAAP loss of $0.09 per share in the same period...

– IND submission for NL-201 anticipated by end of 2020 –– Three abstracts to be presented at AACR-II –SEATTLE, May 06, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced financial results for the first quarter ending March 31, 2020 and provided a business update.“We look forward to presenting significant updates on our preclinical data for NL-201 as well as additional data related to our de novo protein technology next month at the virtual AACR-II meeting,” said Jonathan Drachman, M.D., Chief Executive Officer of Neoleukin. “Our committed team continues to advance NL-201 towards IND, which remains on target for submission by the end of 2020.  In addition,...

HAMILTON, Bermuda, May 06, 2020 (GLOBE NEWSWIRE) — Teekay Corporation (Teekay) (NYSE:TK), Teekay LNG Partners L.P. (Teekay LNG) (NYSE:TGP), and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) plan to release their financial results for the first quarter 2020 before market open on Thursday, May 21, 2020.All shareholders, unitholders and interested parties are invited to listen to the live conference calls by choosing from the following options:By dialing:By accessing the webcasts, which will be available on Teekay’s website at www.teekay.com at the times noted above (the archives will remain on the website for a period of one year).Accompanying First Quarter 2020 Earnings Presentations will also be available at www.teekay.com in advance of the conference call start times.About TeekayTeekay is a leading provider of international...

NEWPORT BEACH, Calif., May 06, 2020 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its first quarter 2020 financial results and provide a business update on Monday, May 11, 2020 after the close of the U.S. financial markets.Management will host a conference call and live webcast to discuss Evolus’ financial results at 4:30 p.m. ET that same day. A question and answer session will follow management remarks.The dial-in numbers for the conference call are (866) 916-2317 for domestic callers and (703) 925-2662 for international callers. The conference ID is 1819528.A replay of the call will be available following its completion through May 18, 2020. To access the replay, dial (855) 859-2056...

MOOREFIELD, W.Va., May 06, 2020 (GLOBE NEWSWIRE) — Summit Financial Group, Inc. (“Company” or “Summit”) (NASDAQ: SMMF) today announced that H. Charles Maddy, III, President and Chief Executive Officer, and Robert S. Tissue, Executive Vice President and Chief Financial Officer will be making virtual presentations at the D.A. Davidson 22nd Annual Financial Institutions Conference May 7-8, 2020.A copy of the presentation materials is available on the Company’s website at www.summitfgi.com. About SummitSummit Financial Group, Inc. is a $2.51 billion financial holding company headquartered in Moorefield, West Virginia. Summit provides community banking services primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, Shenandoah Valley and Southwestern regions of Virginia, through its bank...

LES HOTELS BAVEREZ S.A.2, place des Pyramides 75001 PARISCapital € 10.127.050 – Code NAF 5510 ZR.C.S. PARIS 572 158 558ISIN : FR 0007080254Mnémonique : ALLHBEURONEXT GrowthNombres d’actions et de droits de vote au 30/04/2020Au 30 avril 2020, le nombre total d’actions composant le capital social de la société s’élève à 2 372 468.Le nombre total de droits de vote à la même date est de 3 854 744, inchangé depuis le 29 février 2020.Pièces jointesDeclaration_AMF-DDV_au_30_04_20Declaration_AMF-DDV_au_30_04_20